Pfizer

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Cisco above all other Dow stocks.
Related topics: Intel, Cisco (business)

Read More →

Conatus' Emricasan Lags Primary Goal In Liver Function Study

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report Novartis AG (NVS): Free Stock Analysis...
Related topics: Novartis

Read More →

Pfizer (pfe) Flat As Market Sinks: What You Should Know

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report To read this article on Zacks.com click...

Read More →

Abbvie To Buy Botox-maker Allergan, Look Ahead To G-20

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Caesars Entertainment Corporation (CZR): Free Stock Analysis Report Pfizer Inc....

Read More →

Why These Innovative Biotech Etfs Soaring

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Invitae Corporation (NVTA): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock...

Read More →

Biomarin Gets $15m From Pfizer On Talzenna's European Nod

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report Acorda Therapeutics, Inc. (ACOR): Free...

Read More →

Is Pfizer Overpaying For Array Biopharma?

When Pfizer (NYSE: PFE) opened up its checkbook this week to buy Array Biopharma (NASDAQ: ARRY), it was bidding for a small cancer portfolio that has big potential. But Braftovi and Mektovi, the two metastatic melanoma drugs Array has on the...
Related topics: US Equity Markets, Nasdaq

Read More →

Stock Market News For Jun 20, 2019

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report Merck & Co., Inc. (MRK): Free Stock...
Related topics: Merck & Co

Read More →

Big Drugmakers That May Tread The M&a Path After Pfizer

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report Johnson & Johnson...
Related topics: Bristol-Myers Squibb

Read More →

Cancer/gene Therapy Biotechs In Focus After Pfizer-array Deal

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report uniQure N.V. (QURE): Free Stock...

Read More →

Pfizer (pfe) Gains But Lags Market: What You Should Know

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report To read this article on Zacks.com click...

Read More →

Papa John’s Auditor Swap Is Not A Good Look

In today's Market Foolery, host Chris Hill and Motley Fool analyst Ron Gross look at big retail mix-ups, pharma mergers, and shady restaurant news. Pfizer (NYSE: PFE) dropped $11.5 billion to tuck Array BioPharma (NASDAQ: ARRY) and its cancer...
Related topics: US Equity Markets, Nasdaq

Read More →

Pfizer To Buy Array Biopharma, Broaden Cancer Portfolio

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report Bristol-Myers Squibb Company (BMY):...
Related topics: Bristol-Myers Squibb

Read More →

Protalix (plx) Completes Enrollment In Fabry Disease Study

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sanofi (SNY): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock Analysis...
Related topics: Sanofi

Read More →

Why Iovance Biotherapeutics Stock Jumped Today

Shares of Iovance Biotherapeutics (NASDAQ: IOVA) were up 14.5% as of 3:08 p.m. EDT on Monday. The nice gain appears to be caused by investors' speculation that Iovance could be the target of a buyout by a larger drugmaker, spurred by...
Related topics: Nasdaq, US Equity Markets

Read More →

Why Pfizer's Acquisition Of Array Biopharma Won't Pay Off Anytime Soon

Pfizer (NYSE: PFE) is at it again. After a couple of years without any significant merger and acquisition activity, the big drugmaker  announced on Monday that it's buying Array BioPharma (NASDAQ: ARRY).The price tag on the deal was great news for...
Related topics: US Equity Markets, Nasdaq

Read More →

Big Ticket Mergers Are In Focus

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report Sprint Corporation (S): Free Stock...

Read More →

Amgen/allergan Get Fda Nod For Herceptin Biosimilar Kanjinti

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Roche Holding AG (RHHBY): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock...
Related topics: Amgen

Read More →

Pfizer's (pfe) Xeljanz Effective As Monotherapy In Ra Study

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AbbVie Inc. (ABBV): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock Analysis...

Read More →

Novartis Reports Data On Cosentyx For Psoriatic Arthritis

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report Pfizer Inc. (PFE):...
Related topics: Novartis, Bristol-Myers Squibb

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.